Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor.

Chung KB, Lee EY, Im JP, Han SK, Yim JJ.

Korean J Intern Med. 2013 Mar;28(2):174-9. doi: 10.3904/kjim.2013.28.2.174. Epub 2013 Feb 27.

PMID:
23525649
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.

Jo KW, Hong Y, Jung YJ, Yoo B, Lee CK, Kim YG, Yang SK, Byeon JS, Kim KJ, Ye BD, Lee SD, Kim WS, Kim DS, Shim TS.

Respir Med. 2013 Nov;107(11):1797-802. doi: 10.1016/j.rmed.2013.08.011. Epub 2013 Aug 28.

PMID:
24029000
[PubMed - indexed for MEDLINE]
Free Article
3.

Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.

Malaviya AN, Kapoor S, Garg S, Rawat R, Shankar S, Nagpal S, Khanna D, Furst DE.

J Rheumatol. 2009 Jul;36(7):1414-20. doi: 10.3899/jrheum.081042. Epub 2009 Jun 1.

PMID:
19487263
[PubMed - indexed for MEDLINE]
4.

Clinical features and outcomes of tuberculosis in solid organ transplant recipients.

Bodro M, Sabé N, Santín M, Cruzado JM, Lladó L, González-Costello J, Carratalà J.

Transplant Proc. 2012 Nov;44(9):2686-9. doi: 10.1016/j.transproceed.2012.09.060.

PMID:
23146494
[PubMed - indexed for MEDLINE]
5.

Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis.

Kwon M, Sung M, Kwon YJ, Song YG, Lee SW, Park MC, Park YB, Lee SK, Song JJ.

J Clin Rheumatol. 2014 Mar;20(2):68-73. doi: 10.1097/RHU.0000000000000074.

PMID:
24561408
[PubMed - indexed for MEDLINE]
6.

Evaluating the use of the interferon-γ response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-α therapy: a prospective head-to-head cross-sectional study.

Martyn-Simmons CL, Mee JB, Kirkham BW, Groves RW, Milburn HJ.

Br J Dermatol. 2013 May;168(5):1012-8. doi: 10.1111/bjd.12176.

PMID:
23278714
[PubMed - indexed for MEDLINE]
7.

Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.

Klein M, Jarosová K, Forejtová S, Bečvář R, Sedová L, Pavelka K, Simková G, Svobodová R, Hviscová K, Mann H, Půtová I, Vencovský J.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1):111-7. Epub 2012 Oct 24.

PMID:
23101473
[PubMed - indexed for MEDLINE]
8.

Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.

Theis VS, Rhodes JM.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):19-30. Epub 2007 Oct 16. Review.

PMID:
17944997
[PubMed - indexed for MEDLINE]
Free Article
9.

Follow-up results of 702 patients receiving tumor necrosis factor-α antagonists and evaluation of risk of tuberculosis.

Cagatay T, Aydin M, Sunmez S, Cagatay P, Gulbaran Z, Gul A, Artim B, Kilicaslan Z.

Rheumatol Int. 2010 Sep;30(11):1459-63. doi: 10.1007/s00296-009-1170-6. Epub 2009 Oct 21.

PMID:
19844718
[PubMed - indexed for MEDLINE]
10.

Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.

Mohan AK, Coté TR, Block JA, Manadan AM, Siegel JN, Braun MM.

Clin Infect Dis. 2004 Aug 1;39(3):295-9. Epub 2004 Jul 16.

PMID:
15306993
[PubMed - indexed for MEDLINE]
Free Article
11.

Tuberculosis screening in prescribers of anti-tumor necrosis factor therapy in the European Union.

Smith MY, Attig B, McNamee L, Eagle T.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1168-73. doi: 10.5588/ijtld.12.0029. Epub 2012 Jul 12.

PMID:
22794309
[PubMed - indexed for MEDLINE]
12.

Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.

Denis B, Lefort A, Flipo RM, Tubach F, Lemann M, Ravaud P, Salmon D, Mariette X, Lortholary O; RATIO Group.

Clin Microbiol Infect. 2008 Feb;14(2):183-6. Epub 2007 Dec 10.

PMID:
18076664
[PubMed - indexed for MEDLINE]
13.

Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-α inhibitors.

Papay P, Primas C, Eser A, Novacek G, Winkler S, Frantal S, Angelberger S, Mikulits A, Dejaco C, Kazemi-Shirazi L, Vogelsang H, Reinisch W.

Aliment Pharmacol Ther. 2012 Nov;36(9):858-65.

PMID:
22978645
[PubMed - indexed for MEDLINE]
14.

Use of the T-SPOT.TB assay to detect latent tuberculosis infection among rheumatic disease patients on immunosuppressive therapy.

Behar SM, Shin DS, Maier A, Coblyn J, Helfgott S, Weinblatt ME.

J Rheumatol. 2009 Mar;36(3):546-51. doi: 10.3899/jrheum.080854. Epub 2009 Feb 17.

PMID:
19228655
[PubMed - indexed for MEDLINE]
15.

Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Chang B, Park HY, Jeon K, Ahn JK, Cha HS, Koh EM, Kang ES, Koh WJ.

Clin Rheumatol. 2011 Dec;30(12):1535-41. doi: 10.1007/s10067-011-1771-9. Epub 2011 May 10.

PMID:
21556777
[PubMed - indexed for MEDLINE]
16.

Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Mínguez S, Latorre I, Mateo L, Lacoma A, Diaz J, Olivé A, Domínguez J.

Clin Rheumatol. 2012 May;31(5):785-94. doi: 10.1007/s10067-012-1938-z. Epub 2012 Jan 21.

PMID:
22271230
[PubMed - indexed for MEDLINE]
17.

Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.

Park JH, Seo GY, Lee JS, Kim TH, Yoo DH.

J Rheumatol. 2009 Oct;36(10):2158-63. doi: 10.3899/jrheum.090150. Epub 2009 Sep 1.

PMID:
19723901
[PubMed - indexed for MEDLINE]
18.

[The clinical application of quantiferon TB-2G: its usefulness and limitations].

Sato S, Nagai H.

Kekkaku. 2011 Feb;86(2):101-12. Japanese.

PMID:
21404654
[PubMed - indexed for MEDLINE]
19.

The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.

Chen YM, Chen HH, Lai KL, Hung WT, Lan JL, Chen DY.

Rheumatology (Oxford). 2013 Apr;52(4):697-704. doi: 10.1093/rheumatology/kes365. Epub 2012 Dec 22.

PMID:
23264552
[PubMed - indexed for MEDLINE]
20.

Tuberculosis during TNF-α inhibitor therapy, despite screening.

Hofland RW, Thijsen SF, Verhagen MA, Schenk Y, Bossink AW.

Thorax. 2013 Nov;68(11):1079-80. doi: 10.1136/thoraxjnl-2012-202974. Epub 2013 Apr 18.

PMID:
23598710
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk